FD&C RED NO. 3

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
836.0 6.4 2 4 88.0 2 0.0
UNII
PN2ZH5LOQY
CAS
49746-10-3
SYNONYMS
  • Ci 45430
  • Fd&c Red No. 3
  • Erythrosine Sodium
  • C.i. 45430
  • C.i. Acid Red 51
  • C.i. Food Red 14
  • Erythrosine
  • Erythrosine B
  • Acid Red 51
  • Red 1799
  • E127
  • Erythrosine [mart.]
  • Erythrosine [mi]
  • Acid Red 51 [inci]
  • Ci 45430 [inci]
  • Erythrosine [fcc]
  • Fd&c Red No. 3 [fcc]
  • Aka3 [inci]
  • Food Red 14
  • Japan Red 3
  • Yellow No. 201
  • Aka3
  • Fd&c Red No. 3 [ii]
  • Erythrosine Sodium [usp]
  • Erythrosine [who-Dd]
  • F D & C Red No. 3
  • F D & C Red #3 Aluminum Lake [vandf]
  • F D & C Red #3 [vandf]
  • Red 3
  • Dye Fdc Red #3 [vandf]
  • E-127
  • Ins No.127
  • C.i.(1975)no.45430
  • Ins-127
  • Fd&c Red 3
ZINC ID(s)
Availability
Present in 39 ZINC catalogs

Known Active Genes

This compound has been observed to have activity at 10μM or less against the following gene(s).
Name Description Classification
CHAT Choline O-acetyltransferase Enzyme / Enzyme-Other

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Functions of Fd&c Red No. 3

Dye - Dye

Dosages

Route Formulation Per Unit Dose
Oral Capsule 1.69MG
Oral Capsule (immed./comp. Release) 0.001MG
Oral Capsule, Extended Release 0.05MG
Oral Capsule, Hard Gelatin
Oral Capsule, Soft Gelatin 0.22MG
Oral Capsule, Sustained Action 0.3MG
Oral Drops 0.01%
Oral Granule 0.25MG
Oral Powder, For Oral Suspension 0.01%
Oral Powder, For Solution
Oral Powder, For Suspension 0.04%
Oral Solution, Elixir 0.001%
Oral Suspension 0.02%
Oral Syrup 0.003%
Oral Tablet 2.2MG
Oral Tablet (immed./comp. Release), Uncoated, Chewable 0.05MG
Oral Tablet, Coated 0.5MG
Oral Tablet, Delayed Action, Enteric Coated 0.005MG
Oral Tablet, Extended Release 0.03MG
Oral Tablet, Film Coated 0.004MG
Oral Tablet, Sustained Action
Oral Tablet, Sustained Action, Coated
Oral Tablet
Oral Tablet 0.003MG
Oral Tablet

More Information

Usage Over Time

Comments